E119: The Financial Domain of Perimenopause

The menopause industry is booming, but not every product, test, or treatment is backed by good science. From hormone panels and compounded therapies to supplements, social media influencers, and telemedicine startups, women navigating perimenopause are increasingly being asked to spend money on solutions that may offer little evidence—or prioritize profit over patient care.

In the financial domain of perimenopause, Kirtly Jones, MD, and Katie Ward, PhD, examine the business of perimenopause care through the lens of evidence-based medicine. They revisit the history of hormone therapy, unpack how past research continues to shape public perception, and explore why misinformation can become a profitable business model. The conversation also offers practical guidance for evaluating health claims and finding trustworthy, high-quality care without unnecessary costs.